DAEWOONG

21st Daewoong Pharmaceutical Regular Meeting of Stockholdersview

1. Time

March 29 (Tue), 2023, 09:00

2. Location

Daewoong Pharmaceutical HQ Bear Hall

3. Meeting Objectives

A. Report Items: Audit report and sales report; Report on the 21st financial statement and consolidated financial statement; Report on internal accounting management system operations status

B. Motioned Bills: Agenda 1: Designation of director (one inside director / one outside director); Agenda 2: Approval of director compensation limit; Agenda 3: Approval of auditor compensation limit

Daewoong Pharmaceutical Regular Meeting of Stockholders
No. of stocks issued	No. of stocks with voting rights	No. of stocks attending	No. of stocks attending(majority shareholder and affiliates)	No. of stocks attending, excluding majority shareholder and affiliates	Voting rights, excluding majority shareholder and affiliates(%)
11,586,575	11,069,208	8,666,832	6,528,338	2,138,494	24.67%

Stockholder's meeting, 21st
General	Stockholder's meeting, 21st	2023.3.29

Stockholder's meeting, 21st
Agenda	Type of Resolution (Ordinary/Special)	Motioned Bills	Remarks	No. of stocks with voting rights(①)	No. of stocks attending(A)	stocks, For(B)
						(Ratio, %)
						No. of stocks, Against · Abstain(C)
						(Ratio, %)
Agenda 1-1	Ordinary	Designation of director (nominee Seongsoo Park)	Approved	11,069,208	8,666,832	8,615,979
						(99.41%)
						50,853
						(0.59%)
Agenda 1-2	Ordinary	Designation of director (nominee Yong-Jin Kim)	Approved	11,069,208	8,666,832	8,631,400
						(99.59%)
						35,432
						(0.41%)
Agenda 2	Ordinary	Approval of director compensation limit (3 Bil. Won)	Approved	11,069,208	8,666,832	8,631,364
						(99.59%)
						35,468
						(0.41%)
Agenda 3	Ordinary	Approval of auditor compensation limit (200 Mil. Won)	Approved	11,069,208	8,666,832	8,631,554
						(99.59%)
						35,278
						(0.41%)

20th Daewoong Pharmaceutical Regular Meeting of Stockholdersview

1. Time

March 29 (Tue), 2022, 09:00

2. Location

Daewoong Pharmaceutical HQ Bear Hall

3. Meeting Objectives

A. Report Items: Audit report and sales report; Report on the 20th financial statement and consolidated financial statement; Report on internal accounting management system operations status; Report on outside auditor designation

B. Motioned Bills: Agenda 1: Change of articles of association; Agenda 2: Designation of director (one outside director); Agenda 3: Approval of director compensation limit; Agenda 4: Approval of auditor compensation limit; Agenda 5: Approval of granting stock options

Daewoong Pharmaceutical Regular Meeting of Stockholders
No. of stocks issued	No. of stocks with voting rights	No. of stocks attending	No. of stocks attending(majority shareholder and affiliates)	No. of stocks attending, excluding majority shareholder and affiliates	Voting rights, excluding majority shareholder and affiliates(%)
11,586,575	11,069,208	8,274,125	6,658,336	1,615,789	19.53%

Stockholder's meeting, 20th
General	Stockholder's meeting, 20th	2022.3.29

Stockholder's meeting, 20th
Agenda	Type of Resolution (Ordinary/Special)	Motioned Bills	Remarks	No. of stocks with voting rights(①)	No. of stocks attending(A)	stocks, For(B)
						(Ratio, %)
						No. of stocks, Against · Abstain(C)
						(Ratio, %)
Agenda 1	Special	Change of articles of association	Approved	11,069,208	8,274,125	8,091,942
						(97.80%)
						182,183
						(2.20%)
Agenda 2	Ordinary	Designation of director(nominee Dae-duk Kim)	Approved	11,069,208	8,274,125	8,200,622
						(99.11%)
						73,503
						(0.89%)
Agenda 3	Ordinary	Approval of director compensation limit (3 Bil. Won)	Approved	11,069,208	8,274,125	7,341,889
						(88.73%)
						932,236
						(11.27%)
Agenda 4	Ordinary	Approval of auditor compensation limit (200 Mil. Won)	Approved	11,069,208	8,274,125	8,197,876
						(99.08%)
						76,249
						(0.92%)
Agenda 5	Ordinary	Approval of granting stock options	Approved	11,069,208	8,274,125	8,196,118
						(99.06%)
						78,007
						(0.94%)

19th Daewoong Pharmaceutical Regular Meeting of Stockholdersview

1. Time

March 26 (Fri), 2021, 09:00

2. Location

Daewoong Pharmaceutical HQ Bear Hall

3. Meeting Objectives

A. Report Items: Audit report and sales report; Report on the 19th financial statement and consolidated financial statement; Report on internal accounting management system operations status; Report on outside auditor designation

B. Motioned Bills: Agenda 1: Change of articles of association; Agenda 2: Designation of directors (three executive directors, two outside directors); Agenda 3: Designation of auditor (one fulltime auditor); Agenda 4: Approval of director compensation limit; Agenda 5: Approval of auditor compensation limit; Agenda 6: Approval of granting stock options

18th Daewoong Pharmaceutical Regular Meeting of Stockholdersview

1. Time

March 30 (Fri), 2020, 09:00

2. Location

Daewoong Pharmaceutical HQ Bear Hall

3. Meeting Objectives

A. Report Items: Audit report and sales report; Report on the 18th financial statement and consolidated financial statement; Report on internal accounting management system operations status

B. Motioned Bills: Agenda 2: Change of articles of association; Agenda 3: Case of appointing auditors; Agenda 4: Approval of director compensation limit; Agenda 5: Approval of auditor compensation limit

17th Daewoong Pharmaceutical Regular Meeting of Stockholdersview

1. Time

March 22 (Fri), 2019, 09:00

2. Location

Daewoong Pharmaceutical HQ Bear Hall

3. Meeting Objectives

A. Report Items: Audit report and sales report; Report on the 17th financial statement and consolidated financial statement; Report on internal accounting management system operations status

B. Motioned Bills: Agenda 1: Change of articles of association; Agenda 2: Approval of director compensation limit; Agenda 3: Approval of auditor compensation limit; Agenda 4: Approval of granting stock options

16th Daewoong Pharmaceutical Regular Meeting of Stockholdersview

1. Time

March 23 (Fri), 2018, 09:00

2. Location

Daewoong Pharmaceutical HQ Bear Hall

3. Meeting Objectives

A. Report Items: Audit report and sales report; Report on the 16th financial statement and consolidated financial statement

B. Motioned Bills: Agenda 1: Case of appointing directors (2 in-company directors, 1 outside director); Agenda 2: Approval of director compensation limit; Agenda 3: Approval of auditor compensation limit; Agenda 4: Change of articles of association

Corporate Governance

Stockholder's meeting

Major Agendas and Resolutions of the General Meeting of Stockholders